Compared with the live zoster vaccine, adjuvanted recombinant zoster vaccine had significantly higher vaccine efficacy (VE) against herpes zoster (HZ) and postherpetic neuralgia in older adults. There were also no differences in safety between the 2 vaccines, according to a network meta-analysis of randomized controlled trials published in Vaccine. This systematic review of published randomized…
Antibody titers to the HPV4 vaccine were lower for all HPV serotypes in individuals who were infected with HIV perinatally than those who were exposed to HIV perinatally.
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine is effective in middle-income countries like Argentina.
Rate of complete resolution of CIN2/3 significantly higher for HPV vaccine group versus placebo group.
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant.
There was no increased risk for development of diabetes mellitus type 1 after vaccination for human papilloma virus.
Arguments against vaccination remain consistent within subgroups of individuals.
In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.
SynGEM, an intranasal subunit vaccine that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in actuating lasting immune responses in humans.
